SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

mF International Ltd. is a holding company, which engages in the development and provision of financial trading solutions through its subsidiary. It offers real-time mission critical forex, bullion and commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company was founded by Tai Wai Lam and Chi Weng Tam on June 15, 2022, and is headquartered in Hong Kong.

mF International Ltd - Ordinary Shares - Class A

mF International Ltd

MFI is trending due to a significant price surge following the announcement of a $500M private placement to fund a digital asset treasury strategy, specifically Bitcoin Cash (BCH). The community is actively debating the company's strategic shift into crypto, the potential for dilution from the new share issuance, and whether this is a sustainable move or a classic pump-and-dump scheme, especially given MFI's history and the volatile nature of digital asset investments.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

CAPR is trending as investors eagerly await topline data from its Phase 3 HOPE-3 trial, with community chatter focused on potential outcomes and FDA approval scenarios. Discussions include the possibility of a short squeeze and speculation around the timing of the data release, expected in the coming weeks. Community members are weighing the potential for positive results in treating Duchenne Muscular Dystrophy and the impact on the company's future.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending as investors react to the company's AI strategy and substantial debt, with community discussions focusing on potential risks and opportunities. Concerns about rising credit-default swap costs and reliance on OpenAI are being weighed against Oracle's ongoing investments in AI infrastructure. Investor sentiment appears divided, with some seeing a buying opportunity amid the recent selloff, while others express skepticism about the company's long-term prospects.

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

Scilex Holding Company ($SCLX) is trending amid discussions about its relationship with Datavault AI ($DVLT) and a proposed meme coin dividend for shareholders. The community is focused on the potential for a short squeeze, driven by the mechanics of the dividend distribution and related obligations for short sellers. Some investors express concerns about company management and financial strategy.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), Global Services (BGS), and Boeing Capital (BCC). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The Boeing Capital segment seeks to ensure that Boeing customers have the financing they need to buy and take delivery of their Boeing product and manages overall financing exposure. The company was founded by William Edward Boeing on July 15, 1916 and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending as investors weigh a potential bounce against persistent headwinds. Community members are closely watching for news on the union strike vote and its impact on production, while also considering the recent analyst downgrade and general market weakness. Despite positive order news, concerns linger about execution, profitability, and ongoing certification delays.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly's stock is trending as it approaches a $1 trillion market cap, fueled by excitement around its diabetes and weight-loss drugs like Mounjaro and Zepbound. Community discussions revolve around the company's potential for further growth and possible stock splits, as well as its competition with other players in the GLP-1 market. Some traders are taking profits, while others anticipate continued upward momentum, drawing comparisons to tech giants and speculating about future catalysts.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd.

SUGP is trending as traders discuss its regained NASDAQ compliance, drawing parallels to other Hong Kong-based stocks that have recently experienced significant gains. A substantial contract is noted as a potential catalyst, while community members actively speculate on a potential short squeeze due to the stock's low float and high cost to borrow.

Enviri Corp. engages in the provision of industrial services and engineered products. It operates through the following segments: Harsco Environmental, Clean Earth, and Harsco Rail. The Harsco Environmental segment offers on-site services, under long-term contracts which may contain multiple performance obligations. The Clean Earth segment refers to specialty waste processing and beneficial reuse solutions for hazardous wastes, and soil and dredged materials. The Harsco Rail segment sells railway track maintenance equipment, after-market parts and safety and diagnostic equipment. The company was founded in 1853 and is headquartered in Philadelphia, PA.

Enviri Corp

Harsco Corp.

Shares of NVRI are trending after the company announced the sale of its Clean Earth business to Veolia for $3.04 billion and a spin-off of its other businesses into a new entity. The community is discussing the potential per-share value for shareholders following the deal, with some estimating significant upside. Some traders are watching for breakout levels and potential profit-taking opportunities.

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Princeton, NJ.

Palatin Technologies Inc.

Palatin Technologies ($PTN) is trending due to significant volatility and community discussion around a recent run-up and subsequent trading halts. Chatter revolves around whether the stock is a low-float rocket or a pump and dump, with some highlighting insider buying as a positive sign, while others point to dilution concerns and the company's history.

CCH Holdings Ltd. engages in operating a chicken restaurant. It offers catering services in Malaysia and outside Malaysia under the brand name, Chicken Claypot House for its chicken hotpot restaurants and Zi Wei Yuan for its fish head hotpot restaurants. The company was founded by Goh Kok Foong on December 2, 2024 and is headquartered in Seberang Perai, Malaysia.

CCH Holdings Ltd

CCHH is trending as traders discuss its recent climb since its October IPO, with some anticipating further gains. The community is debating potential price targets and speculating on whether the stock is being manipulated for a pump-and-dump scheme. Some traders are taking profits, while others suggest holding for a possible run to double digits.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sharps Technology (NASDAQ:STSS) Releases Quarterly Earnings Results

Sharps Technology (NASDAQ:STSS - Get Free Report) posted its earnings results on Friday. The company reported ($4.02) earnings per share (EPS) for the quarter...

Sharps Technology (STSS) announced on Thursday that it has partnered with Coinbase to help manage its growing Solana (SOL) holdings, which now total over two million tokens.<a href="http://stocktwits.com/symbol/SOL.X">Solana’s price</a> gained 1.2% in the last 24 hours, trading at around $223 – the only cryptocurrency among the top 10 by market capitalization in the green during early morning trade. At Solana’s current price, Sharp’s holdings are worth around $447 million.&nbsp;On Stocktwits, however, retail sentiment around the altcoin edged lower into ‘neutral’ from ‘bullish’ territory over the past day.Through the partnership, Sharps will use Coinbase Prime for secure custody and over-the-counter (OTC) trading of its Solana assets.Despite the announcement,&nbsp;<a href="http://stocktwits.com/symbol/STSS">STSS’s stock</a> was down 3.4% in the pre-market trade. Retail sentiment also dived to ‘bearish’ from ‘extremely bullish’ the previous day on Stocktwits. Chatter dipped to ‘extremely low’ from ‘high’ levels.<a href="http://stocktwits.com/symbol/COIN">COIN’s stock</a> was also in the red, edging lower by 0.73% in pre-market trade. Retail sentiment around the shares remained in ‘bullish’ territory, but chatter fell to ‘normal’ from ‘high’ levels over the past day.&nbsp;Sharps first revealed its pivot to a Solana-focused treasury strategy in August through a $400 million private placement, aiming to build the largest Solana digital asset treasury (DAT) without disclosing a specific target of the total circulating supply. This move was later followed by a collaboration with Crypto.com in late September, announcing a similar partnership as with Coinbase for custody infrastructure and OTC desk.&nbsp;Platform data shows that retail chatter around Sharps’ stock has increased 33.3% over the past month and 150% over the last three months.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-ethereum-dip-ahead-of-powell-speech-amid-rising-dollar/ch67FDVR3K0">Bitcoin, Ethereum, And Other Major Cryptocurrencies Dip Ahead Of Powell’s Speech Amid Rising Dollar</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Sharps Technology logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Sharps Technology Partners With Coinbase To Manage Solana Holdings Worth $447 Million

Through the partnership, Sharps will use Coinbase Prime for secure custody and over-the-counter trading of its Solana assets.

Sharps Technology Partners With Coinbase To Manage Solana Holdings Worth $447 Million 

Equity

Sharps Technology Expands Digital Asset Treasury Strategy with Coinbase

Sharps Technology Expands Digital Asset Treasury Strategy with Coinbase Sharps Technology Expands Digital Asset Treasury Strategy with Coinbase PR Newswire NEW YORK, Oct. 9, 2025 NEW YORK, Oct. 9...

Sharps Technology Inc. (STSS) announced on Thursday the launch of a share buyback program worth up to $100 million, aiming to repurchase a portion of its outstanding common stock.&nbsp;The repurchase authorization will enable the company to acquire shares through either public market purchases or privately negotiated deals, depending on market conditions.Following the announcement, Sharps Technology's stock traded over 1% higher in Thursday’s premarket and was the third-most trending equity ticker on Stocktwits. Retail sentiment around the stock jumped to ‘bullish’ from ‘bearish’ territory the previous day. Message volume improved to ‘low’ from ‘extremely low’ in 24 hours.&nbsp;&nbsp;A bullish Stocktwits user sounded optimistic about the stock’s growth.&nbsp;<stembedurl>https://stocktwits.com/VSWeWork/message/630746824</stembedurl>Sharps Technology is a medical device company that now uses a digital asset strategy centered on collecting SOL, the main cryptocurrency of the Solana blockchain.&nbsp;In August, Sharps&nbsp;announced that it is looking to establish a Solana digital asset treasury by raising over $400 million in a private placement offering.&nbsp;&nbsp;Consequently, in September, Sharps announced its first acquisition of Solana tokens as part of its digital asset treasury strategy. Funded by the recent PIPE equity raise, the company now holds over two million SOL, creating a SOL treasury currently valued at over $400 million.On Monday,&nbsp;Sharps Technology entered into a partnership with Crypto.com to boost its digital asset treasury management capabilities. Sharps Technology stock has lost over 98% of its value year-to-date.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-nebius-stock-rising-pre-market/chCrJUNR3OF">Why Is Nebius Stock Rising Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Sharps Technology Stock Rises Following $100M Buyback Program – Find Out More

The repurchase authorization will enable Sharps Technology to acquire shares through either public market purchases or privately negotiated deals.

Medical device company Sharps Technology, Inc. (STSS) on Monday announced that it is looking to establish a Solana digital asset treasury by raising over $400 million in a private placement offering. &nbsp;The offering will support the company’s plans to adopt a digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of the Solana blockchain, the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/sharps-technology-inc-announces-over-400-million-private-placement-seeking-to-establish-the-largest-solana-digital-asset-treasury-strategy-302537587.html">said</a>.The offering consists of an over $400 million private investment in public equity transaction for the purchase and sale of common stock and stapled warrants to purchase shares of common stock at a purchase price of $6.50 per unit. The stapled warrants will be exercisable for a period of three years and have an exercise price equal to $9.75.Investors include ParaFi, Pantera, Monarq, FalconX, Phoenix Capital, Bastion Trading, RockawayX, Syncracy, Borderless, Republic Digital, Arche Capital, CoinFund, Arrington Capital, Quantstamp, CoinList Alpha, Primitive Ventures, Avenir, Hypersphere, and more, the company said.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/STSS">STSS stock</a> jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels. The stock traded 54% higher in the pre-market session at the time of writing.<figure class="image"><img style="aspect-ratio:574/63;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_25_at_8_29_34_AM_png_1dc7b14fd2.webp" alt="STSS's Sentiment Meter and Message Volume as of 8:29 a.m. ET on Aug. 25, 2025 | Source: Stocktwits" width="574" height="63"><figcaption>STSS's Sentiment Meter and Message Volume as of 8:29 a.m. ET on Aug. 25, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user sees the stock crossing $13 on Monday.<stembedurl>https://stocktwits.com/2moroisanewday/message/626407772</stembedurl>Another user expressed confidence in the company’s future.<stembedurl>https://stocktwits.com/yaemmi/message/626406186</stembedurl>The company said that it intends to use the net proceeds from the offering primarily to fund the acquisition of SOL in the open market and the establishment of the company's SOL treasury operations. Chief Investment Officer Alice Zhang highlighted that Solana’s ecosystem is accelerating.“We will have a team with deep ties to the Solana ecosystem and proven founder-level experience in scaling institutional digital asset platforms, which we believe will set the company up for success," Zhang said.STSS stock is down by 99% this year and has lost nearly all its value over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/alibaba-stock-sees-retail-chatter-spike-340-ahead-of-earnings/chssFwcRd1Y">Alibaba Stock Sees Retail Chatter Spike 340% Ahead Of Earnings: AI Investment And E-Commerce In Focus</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Sharps Technology Stock Just Rocketed 54% Today – Here’s What Happened

The company is looking to raise over $400 million in a private placement offering and said that it intends to use the net proceeds primarily to fund the acquisition of SOL in the open market and the establishment of its SOL treasury operations.

Shares of Sharps Technology, Inc. (STSS) traded 24% higher by Wednesday noon after the company received a $400,000 purchase <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/04/30/3071190/0/en/Sharps-Technology-Secures-400K-Initial-Purchase-Order-from-U-S-Leader-in-IV-Flushing-Solutions-as-Part-of-50-Million-SoloGard-Supply-Agreement.html">order</a> from an IV flushing solutions provider.The medical device and pharmaceutical packaging company said that this is the first order under a $50 million supply agreement announced in July. Under the agreement, Sharps will supply approximately 500 million customized 10 mL SoloGard syringes to the U.S.-based supplier of medical saline and water products over five years.CEO Roberty Hayes noted that the order represents a transformative moment for Sharps Technology as it begins generating revenue.“Our strategic partnership is now moving from the agreement to the execution phase, with this initial order serving as the foundation for accelerating volume in the quarters ahead,” Hayes said. “We look forward to advancing this supply agreement and delivering long-term value to our shareholders.”The company’s Hungarian manufacturing facility is fully prepared to deliver these first orders of pump-compatible 10mL SoloGard syringes, he added. Revenue from the order will mark Sharps’ first revenue of 2025.The company has invested in advanced production technology for SoloGard manufacturing and will soon begin installation and operational qualification to support increased production capacity, the company said.Earlier this month, Sharps announced that it will effect a 1-for-300 reverse stock split of its common stock to bring it into compliance with Nasdaq’s minimum bid price requirement of $1 for continued listing on the exchange.<a href="https://stocktwits.com/symbol/STSS">STSS stock</a> is down by over 99% this year.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/pce-index-stagnates-in-march/chXTWypRbiE">PCE Index: Fed’s Preferred Gauge Of Inflation Stagnates In March, Consumer Spending Picks Up</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Sharps Technology To Begin Generating Revenue, Stock Shoots Up On $400K Order 

The company said that this is the first order under a $50 million supply agreement announced in July.

Sharps Technology Stock Rockets On New Purchase Order

Three nano-cap healthcare stocks drew massive attention from retail investors on Stocktwits Tuesday, though not all for positive reasons.Trinity Biotech (<a href="https://stocktwits.com/symbol/TRIB">TRIB</a>)&nbsp;Shares of the medical diagnostic products maker saw a staggering 15,550% jump in retail message volume after the company released “compelling” results from a study on its next-generation continuous glucose monitoring system.&nbsp;The device, designed for real-time diabetes management, demonstrated superior signal quality, accuracy, and consistency in a trial involving 30 diabetic participants.&nbsp;The system features a reusable applicator and rechargeable wearable transmitter, reducing costs by eliminating disposable components.&nbsp;Trinity said it remains on track to seek regulatory approval in the EU by 2025 and the U.S. by 2026.&nbsp;Shares fell over 13% premarket Wednesday.Silexion Therapeutics (<a href="https://stocktwits.com/symbol/SLXN">SLXN</a>)&nbsp;The cancer-focused biotech firm’s ticker saw a 9,060% surge in retail message volume as its stock more than doubled Tuesday following promising preclinical data for its tumor drug candidate SIL-204.&nbsp;The company reported that the extended-release formulation of SIL-204 reduced tumor growth by more than 50% after 30 days, with around 50% of tumors showing complete necrosis in human pancreatic models.&nbsp;Additionally, an injectable version of the drug candidate showed tumor growth inhibition in metastatic pancreatic mouse models.&nbsp;The stock continued its rally, gaining over 70% premarket Wednesday.Sharps Technology (<a href="https://stocktwits.com/symbol/STSS">STSS</a>)&nbsp;The medical packaging firm experienced a 6,233% surge in retail message volume, but for the wrong reasons.&nbsp;Shares plunged nearly 70% to a record low on Tuesday after the company announced a $20 million public offering of 14,285,714 Common Units.&nbsp;Each unit consists of one share of common stock, one Series A warrant, and one Series B warrant, priced at $1.40 per unit, a 4.1% discount to Monday’s close.&nbsp;The company said the proceeds would be used for general corporate purposes and working capital.&nbsp;The stock continued to slide, down over 2% premarket Wednesday.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stockbroker analyzing financial stock market with reflection on eyeglasses. Photo via Westend61 on Getty Images

TRIB, SLXN, STSS: Why Retail Chatter On 3 Nano-Cap Healthcare Stocks Exploded Over 6000%

“Compelling” results from a study, promising pre-clinical data and a public offering got Stocktwits investors buzzing on Tuesday.

Nasdaq Surges Over 100 Points; Sharps Technology Shares Spike Higher

What's Going On With Nano-Cap Medical Device-Focused Sharps Technology On Friday?

Sharps Technology shares surge as the company receives orders for 1 million SecureGard syringes from a Swiss provider of injectable therapies. First shipment in July; subsequent deliveries through...

Why Sharps Technology Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket

Shares of Sharps Technology, Inc. (NASDAQ:STSS) rose sharply in today's pre-market trading after the company announced it received two purchase orders for a total of approximately one million...

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. It also focuses on low waste, and ultra-low waste syringe technologies that incorporate both passive and active safety features. The company was founded by Alan R. Blackman and Barry B. Berler on December 16, 2017 and is headquartered in Melville, NY.

STSS
Sharps Technology Inc

Feed

News

Sentiment

Fundamentals

Info

Latest STSS News

STSSSharps Technology Inc